Telus Health Solutions (Toronto: T.TO) and Orange have come together to target new remote health opportunities for chronic disease patients.
Orange reported that during a recent trial of the Calydial solution, which leverages Telus' remote patient monitoring (RPM) system, an improvement in patient satisfaction and support at Grenoble University Hospital, Calydial dialysis centers of Lyon, France and AGDUC health center in Grenoble, France.
During the pilot, chronic kidney disease patients took part in a trial using the joint Telus and Orange RPM solution at their respective homes. Participants were supplied with a tablet computer, connectivity and software to monitor their vital signs, manage their medication and treatment protocols and provide feedback to their care team. Based on the early positive results of the trial, Orange and Telus plan to replicate the program at other health care institutions in France and Canada and for other chronic diseases.
Both patients and their caregivers were able to access the application through Orange wireline and wireless-based network connections.
Kasra Moozar, vice president of TELUS Health Solutions, saidm, "With Orange we have the opportunity to extend our reach into international markets, bringing our award-winning and proven solutions to further healthcare improvement objectives by turning information into better health outcomes for citizens."
- see the release
Canada takes cautious approach to increasing foreign telecom ownership
Telus Q3 revenues rise to $2.55B on wireline, wireless data growth
Orange Business Services, Verizon establish telepresence pact